Multiple human clinical trials conducted with formulas containing fat blends with approximately 20% palmitic acid of which at least 40% was in the sn-2 position, may exert the following benefits to young infants
INFAT® may result in longer sleep duration in the first months of life, compared to standard infant formula. [7]
INFAT® may help reduce crying duration during the first months of life with a pattern closer to that of breast-fed infants, compared to standard infant formula. [6-7]
INFAT® may support or contribute to softer stools in the first months of life, compared to standard formula. [1, 4-5]
INFAT® may increase bone mineral content as compared to standard infant formula in the first months of life [1,3-4]
INFAT® may support calcium absorption by reducing calcium excretion (as fatty acid salts), compared to standard formula. [2].
INFAT® may support fat absorption by reducing fecal palmitic acid as compared to standard infant formula. [1,2]
INFAT® may support a healthy gut microbiome similar to breast fed infants during first months of life. [5,8]
Multiple human clinical trials conducted with formulas containing fat blends with approximately 20% palmitic acid of which at least 40% was in the sn -2 position, may exert the benefits to young infants
1. Kennedy K., et al., Am J Clin Nutr. 70: p.920. 1999.
2. Bar-Yoseph F., et al., J Pediatr Gastroenterol Nutr. 62(2): p. 341. 2016.
3. Litmanovitz I., et al., Calcif Tissue Int. 92: p. 35-41. 2013.
4. Béghin L., et al., Clin Nutr. 38(3): p. 1023-1030. 2019.
5. Yao M., et al., J Pediatr Gastroenterol Nutr. 59(4): p. 440. 2014.
6. Litmanovitz I., et al., BMC Pediatr. 14: p. 1-6. 2014.
7. Bar-Yoseph F., et al., Clin Mother Child Health. 14(2). 2017.
8. Yaron S., et al., J Pediatr Gastroenterol Nutr. 56(4): p. 376-381. 2013.